Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 KPC screening by updated BD Phoenix and Vitek 2 automated systems.

Literature DB >> 21734025

KPC screening by updated BD Phoenix and Vitek 2 automated systems.

Kenneth S Thomson¹, Iraida E Robledo, Guillermo J Vázquez, Ellen S Moland.

Abstract

Current BD Phoenix and Vitek 2 methodologies were assessed as screens for KPC β-lactamases. Using carbapenem MICs or expert system interpretations as screens, both systems exhibited high (97%) sensitivity in tests with 103 well-characterized Gram-negative isolates, 77 of which were KPC producers.

Entities: Chemical

Mesh：

Substances：

Year: 2011 PMID： 21734025 PMCID： PMC3165580 DOI： 10.1128/JCM.00772-11

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

18 in total

Review 1. Carbapenemases: the versatile beta-lactamases.

Authors: Anne Marie Queenan; Karen Bush
Journal: Clin Microbiol Rev Date: 2007-07 Impact factor: 26.132

2. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Authors: Andrea Endimiani; Gopi Patel; Kristine M Hujer; Mahesh Swaminathan; Federico Perez; Louis B Rice; Michael R Jacobs; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2009-11-09 Impact factor: 5.191

3. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Authors: Simona Bratu; David Landman; Robin Haag; Rose Recco; Antonella Eramo; Maqsood Alam; John Quale
Journal: Arch Intern Med Date: 2005-06-27

4. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors: Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal: Antimicrob Agents Chemother Date: 2005-07 Impact factor: 5.191

5. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.

Authors: George L Daikos; Panayiotis Petrikkos; Mina Psichogiou; Chris Kosmidis; Evangelos Vryonis; Athanasios Skoutelis; Kleoniki Georgousi; Leonidas S Tzouvelekis; Panayotis T Tassios; Christina Bamia; George Petrikkos
Journal: Antimicrob Agents Chemother Date: 2009-02-17 Impact factor: 5.191

6. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.

Authors: Scott A Weisenberg; Daniel J Morgan; Rosanny Espinal-Witter; Davise H Larone
Journal: Diagn Microbiol Infect Dis Date: 2009-04-02 Impact factor: 2.803

7. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

Authors: K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel
Journal: J Clin Microbiol Date: 2007-06-20 Impact factor: 5.948

8. Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.

Authors: Marco Falcone; Maria Lina Mezzatesta; Mariagrazia Perilli; Chiara Forcella; Alessandra Giordano; Viviana Cafiso; Gianfranco Amicosante; Stefania Stefani; Mario Venditti
Journal: J Clin Microbiol Date: 2009-09-09 Impact factor: 5.948

KPC screening by updated BD Phoenix and Vitek 2 automated systems.

Review 1. Carbapenemases: the versatile beta-lactamases.

2. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

3. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

4. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

5. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.

6. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.

7. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

8. Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.

9. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.

Review 10. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature.

1. The Immaculate Carbapenemase Study.

Review 2. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

3. Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay.